Isoprene Pharmaceuticals Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 2

Isoprene Pharmaceuticals General Information

Description

Developer of oral therapeutics designed to treat triple-negative breast cancer. The company is focused on oncology applications of the novel small-molecule protein degrader, helping medical professionals treat oncology, dermatology, inflammatory bowel disorders (IBDs), and other diseases.

Contact Information

Website
www.isoprenepharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 801 West Baltimore Street
  • Suite 502J
  • Baltimore, MD 21201
  • United States
+1 (410)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 801 West Baltimore Street
  • Suite 502J
  • Baltimore, MD 21201
  • United States
+1 (410)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Isoprene Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 07-Sep-2021 $2M Completed Startup
1. Early Stage VC 01-Jan-2021 Completed Startup
To view Isoprene Pharmaceuticals’s complete valuation and funding history, request access »

Isoprene Pharmaceuticals Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
UM Ventures Venture Capital Minority
To view Isoprene Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Isoprene Pharmaceuticals FAQs

  • When was Isoprene Pharmaceuticals founded?

    Isoprene Pharmaceuticals was founded in 2018.

  • Where is Isoprene Pharmaceuticals headquartered?

    Isoprene Pharmaceuticals is headquartered in Baltimore, MD.

  • What industry is Isoprene Pharmaceuticals in?

    Isoprene Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Isoprene Pharmaceuticals a private or public company?

    Isoprene Pharmaceuticals is a Private company.

  • What is Isoprene Pharmaceuticals’s current revenue?

    The current revenue for Isoprene Pharmaceuticals is .

  • Who are Isoprene Pharmaceuticals’s investors?

    National Institutes of Health and UM Ventures have invested in Isoprene Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process